Follow
David N. Frick
Title
Cited by
Cited by
Year
The MutT proteins or “Nudix” hydrolases, a family of versatile, widely distributed,“housecleaning” enzymes
MJ Bessman, DN Frick, SF O'Handley
Journal of Biological Chemistry 271 (41), 25059-25062, 1996
7891996
DNA primases
DN Frick, CC Richardson
Annual review of biochemistry 70 (1), 39-80, 2001
4612001
Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug
E Mastrangelo, M Pezzullo, T De Burghgraeve, S Kaptein, B Pastorino, ...
Journal of Antimicrobial Chemotherapy 67 (8), 1884-1894, 2012
4592012
PSI-7851, a Pronucleotide of β-d-2′-Deoxy-2′-Fluoro-2′-C-Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus …
AM Lam, E Murakami, C Espiritu, HMM Steuer, C Niu, M Keilman, H Bao, ...
Antimicrobial agents and chemotherapy 54 (8), 3187-3196, 2010
2052010
The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target
DN Frick
Current issues in molecular biology 9 (1), 1-20, 2007
1792007
Studies on the ADP-ribose pyrophosphatase subfamily of the nudix hydrolases and tentative identification of trgB, a gene associated with tellurite resistance
CA Dunn, SF O'Handley, DN Frick, MJ Bessman
Journal of Biological Chemistry 274 (45), 32318-32324, 1999
1781999
Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase
AMI Lam, DN Frick
Journal of virology 80 (1), 404-411, 2006
1642006
The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently
DN Frick, RS Rypma, AMI Lam, B Gu
Journal of Biological Chemistry 279 (2), 1269-1280, 2004
1422004
Development of novel therapies for hepatitis C
SM Lemon, JA McKeating, T Pietschmann, DN Frick, JS Glenn, ...
Antiviral research 86 (1), 79-92, 2010
1312010
Understanding helicases as a means of virus control
DN Frick, AMI Lam
Current pharmaceutical design 12 (11), 1315-1338, 2006
1222006
Solution structure of the MutT enzyme, a nucleoside triphosphate pyrophosphohydrolase
C Abeygunawardana, DJ Weber, AG Gittis, DN Frick, J Lin, AF Miller, ...
Biochemistry 34 (46), 14997-15005, 1995
1151995
Discovering new medicines targeting helicases: challenges and recent progress
WR Shadrick, J Ndjomou, R Kolli, S Mukherjee, AM Hanson, DN Frick
Journal of biomolecular screening 18 (7), 761-781, 2013
1132013
Cloning, Purification, and Properties of a Novel NADH Pyrophosphatase: EVIDENCE FOR A NUCLEOTIDE PYROPHOSPHATASE CATALYTIC DOMAIN IN MutT-LIKE ENZYMES (∗)
DN Frick, MJ Bessman
Journal of Biological Chemistry 270 (4), 1529-1534, 1995
1071995
Molecular basis for ADP-ribose binding to the Mac1 domain of SARS-CoV-2 nsp3
DN Frick, RS Virdi, N Vuksanovic, N Dahal, NR Silvaggi
Biochemistry 59 (28), 2608-2615, 2020
952020
DNA damage alters DNA polymerase δ to a form that exhibits increased discrimination against modified template bases and mismatched primers
X Meng, Y Zhou, S Zhang, EYC Lee, DN Frick, MYWT Lee
Nucleic acids research 37 (2), 647-657, 2009
932009
Solution Structure of the Quaternary MutT−M2+−AMPCPP−M2+ Complex and Mechanism of Its Pyrophosphohydrolase Action,
J Lin, C Abeygunawardana, DN Frick, MJ Bessman, AS Mildvan
Biochemistry 36 (6), 1199-1211, 1997
921997
Orf186 represents a new member of the Nudix hydrolases, active on adenosine (5′) triphospho (5′) adenosine, ADP-ribose, and NADH
SF O'Handley, DN Frick, CA Dunn, MJ Bessman
Journal of Biological Chemistry 273 (6), 3192-3197, 1998
891998
A Novel GDP-Mannose Mannosyl Hydrolase Shares Homology with the MutT Family of Enzymes (∗)
DN Frick, BD Townsend, MJ Bessman
Journal of Biological Chemistry 270 (41), 24086-24091, 1995
881995
Helicases as antiviral drug targets
DN Frick
Drug news & perspectives 16 (6), 355, 2003
872003
Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replication
S Mukherjee, WS Weiner, CE Schroeder, DS Simpson, AM Hanson, ...
ACS chemical biology 9 (10), 2393-2403, 2014
852014
The system can't perform the operation now. Try again later.
Articles 1–20